Enzrel Inc.

Calculating rank

USPTO Granted Patents = 6

% Expired Patents = 50.0

Forward Citations = 58

Loading Chart...

4 inventors (with patents filed for the assignee):

Milton Yatvin (6 out of 24 patents)

Richard L Pederson (4 out of 40 patents)

Guru V Betageri (1 out of 16 patents)

4. Michael J Meredith (1 out of 12 patents)

6 patents: Sort by Forward Citations

1. 7045543 - Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites (2006-05-16),

2. 6824790 - Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds (2004-11-30),

3. 6761901 - Liposome drug delivery (2004-07-13),

4. 6689760 - Anti-mycobacterial compositions (2004-02-10),

5. 6664257 - Anti-mycobacterial compounds (2003-12-16),

6. 6455073 - Covalent microparticle-drug conjugates for biological targeting (2002-09-24),

Company Overview

Enzrel Inc. is a leading biopharmaceutical company focused on developing innovative therapies for a wide range of medical conditions. With a team of dedicated scientists and researchers, Enzrel is dedicated to advancing the field of medicine and improving the lives of patients around the world.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#159 in Portland, OR

#496 in Oregon

#45,030 in US

Portland, OR, United States of America

Enzrel Inc.

Forward Citations = 58

4 inventors:

Milton Yatvin (6 out of 24 patents)

Richard L Pederson (4 out of 40 patents)

Guru V Betageri (1 out of 16 patents)

4. Michael J Meredith (1 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Enzrel Inc.. Retrieved from https://idiyas.com/company/enzrel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]